-
1
-
-
52649178068
-
-
Churg J, Strauss L (1951) Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 27: 277-301
-
(1951)
Am J Pathol
, vol.27
, pp. 277
-
-
Churg1
-
2
-
-
0028158243
-
-
Jennette JC, Falk RJ, Andrassy K et al. (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187-192
-
(1994)
Arthritis Rheum
, vol.37
, pp. 187
-
-
Jennette1
-
3
-
-
0025091391
-
-
Masi AT, Hunder GG, Lie JT et al. (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33: 1094-1100
-
(1990)
Arthritis Rheum
, vol.33
, pp. 1094
-
-
Masi1
-
4
-
-
0029155630
-
-
Churg A, Brallas M, Cronin SR et al. (1995) Formes frustes of Churg-Strauss syndrome. Chest 108: 320-323
-
(1995)
Chest
, vol.108
, pp. 320
-
-
Churg1
-
5
-
-
13444300935
-
-
Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R et al. (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53: 93-99
-
(2005)
Arthritis Rheum
, vol.53
, pp. 93
-
-
Reinhold-Keller1
-
6
-
-
20444493937
-
-
Harrold LR, Andrade SE, Go AS et al. (2005) Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective. J Rheumatol 32: 1076-1080
-
(2005)
J Rheumatol
, vol.32
, pp. 1076
-
-
Harrold1
-
7
-
-
33750690162
-
-
Hellmich B, Metzler C, Gross WL (2006) Churg-Strauss syndrome - recent developments in diagnosis and treatment. Dtsch Med Wochenschr 131: 2270-2274
-
(2006)
Dtsch Med Wochenschr
, vol.131
, pp. 2270
-
-
Hellmich1
-
8
-
-
44849141069
-
Eotaxin-3 is involved in Churg-Strauss Syndrome
-
(in Druck)
-
Polzer K, Karonitsch T, Neumann T et al. (2008) Eotaxin-3 is involved in Churg-Strauss Syndrome. Rheumatology (in Druck)
-
(2008)
Rheumatology
-
-
Polzer, K.1
Karonitsch, T.2
Neumann, T.3
-
9
-
-
0032899221
-
Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients
-
(Baltimore)
-
Guillevin L, Cohen P, Gayraud M et al. (1999) Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 78: 26-37
-
(1999)
Medicine
, vol.78
, pp. 26-37
-
-
Guillevin, L.1
Cohen, P.2
Gayraud, M.3
-
10
-
-
0021952573
-
-
Manger BJ, Krapf FE, Gramatzki M et al. (1985) IgE-containing circulating immune complexes in Churg-Strauss vasculitis. Scand J Immunol 21: 369-373
-
(1985)
Scand J Immunol
, vol.21
, pp. 369
-
-
Manger1
-
11
-
-
27644529997
-
-
Sable-Fourtassou R, Cohen P, Mahr A et al. (2005) Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 143: 632-638
-
(2005)
Ann Intern Med
, vol.143
, pp. 632
-
-
Sable-Fourtassou1
-
12
-
-
0031228041
-
-
Chanana A, Sharma OP (1997) Pulmonary involvement in unusual multisystem disorders. Curr Opin Pulm Med 3: 384-390
-
(1997)
Curr Opin Pulm Med
, vol.3
, pp. 384
-
-
Chanana1
-
13
-
-
34548783916
-
-
Hellmich B, Holl-Ulrich K, Gross WL (2007) [Hypereosinophilic syndrome - recent developments in diagnosis and treatment]. Dtsch Med Wochenschr 132: 1892-1896
-
(2007)
Dtsch Med Wochenschr
, vol.132
, pp. 1892
-
-
Hellmich1
-
14
-
-
0344987881
-
-
Cools J, DeAngelo DJ, Gotlib J et al. (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348: 1201-1214
-
(2003)
N Engl J Med
, vol.348
, pp. 1201
-
-
Cools1
-
15
-
-
0032724222
-
-
Potter MB, Fincher RK, Finger DR (1999) Eosinophilia in Wegener's granulomatosis. Chest 116: 1480-1483
-
(1999)
Chest
, vol.116
, pp. 1480
-
-
Potter1
-
16
-
-
0030070089
-
Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients
-
(Baltimore)
-
Guillevin L, Lhote F, Gayraud M et al. (1996) Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 75: 17-28
-
(1996)
Medicine
, vol.75
, pp. 17-28
-
-
Guillevin, L.1
Lhote, F.2
Gayraud, M.3
-
17
-
-
15044343279
-
-
Metzler C, Hellmich B, Gause A et al. (2004) Churg Strauss syndrome - successful induction of remission with methotrexate and unexpected high cardiac and pulmonary relapse ratio during maintenance treatment. Clin Exp Rheumatol 22: S52-61
-
(2004)
Clin Exp Rheumatol
, vol.22
, pp. 52
-
-
Metzler1
-
18
-
-
0036993235
-
-
Arbach O, Gross WL, Gause A (2002) Treatment of refractory Churg-Strauss-Syndrome (CSS) by TNF-alpha blockade. Immunobiology 206: 496-501
-
(2002)
Immunobiology
, vol.206
, pp. 496
-
-
Arbach1
-
19
-
-
33645123007
-
-
Koukoulaki M, Smith KG, Jayne DR (2006) Rituximab in Churg-Strauss syndrome. Ann Rheum Dis 65: 557-559
-
(2006)
Ann Rheum Dis
, vol.65
, pp. 557
-
-
Koukoulaki1
-
20
-
-
0036085775
-
-
Rutberg SA, Ward DE, Roth BJ (2002) Churg-Strauss syndrome and pregnancy: successful treatment with intravenous immunoglobulin. J Clin Rheumatol 8: 151-156
-
(2002)
J Clin Rheumatol
, vol.8
, pp. 151
-
-
Rutberg1
-
21
-
-
0032168695
-
-
Tatsis E, Schnabel A, Gross WL (1998) Interferon-alpha treatment of four patients with the Churg-Strauss syndrome. Ann Intern Med 129: 370-374
-
(1998)
Ann Intern Med
, vol.129
, pp. 370
-
-
Tatsis1
-
22
-
-
25444463072
-
Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: A retrospective analysis of causes and factors predictive of mortality based on 595 patients
-
(Baltimore)
-
Bourgarit A, Le Toumelin P, Pagnoux C et al. (2005) Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine (Baltimore) 84: 323-330
-
(2005)
Medicine
, vol.84
, pp. 323-330
-
-
Bourgarit, A.1
Le Toumelin, P.2
Pagnoux, C.3
|